Yahoo News
Teladoc expands telehealth services to capture obesity drug market
(Reuters) -Teladoc Health Inc is expanding its telehealth services to include prescribing obesity drugs such as Novo Nordisk's Wegovy, in the latest sign of growing interest in a multi-billion dollar market. Shares of the company jumped 11% after Teladoc announced its foray into the weight-loss drugs market, which is globally expected to grow to $50 billion in sales by 2030. Last month, WW International Inc, known as WeightWatchers, announced its acquisition of subscription telehealth platform Sequence, moving the weight-loss program operator into the obesity drug prescription business.